Delayed Postoperative Arousal following Remifentanil-based Anesthesia in a Myasthenic Patient Undergoing Thymectomy [9]

Anesthesiology

Volumn 100, Issue 2, 2004, Pages 460-461

  Baraka, Anis S ^a   Haroun Bizri, Sanie' T ^b   Gerges, Frederic J ^b  

^a AMERICAN UNIVERSITY OF BEIRUT   (Lebanon)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; ANESTHETIC AGENT; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; ESTERASE; GLYCOPYRRONIUM BROMIDE; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; OPIATE; PROPOFOL; PYRIDOSTIGMINE; REMIFENTANIL; SEVOFLURANE; SUXAMETHONIUM;

ADULT; AROUSAL; CASE REPORT; CHOLINESTERASE INHIBITION; ELECTROMYOGRAPHY; FEMALE; GENERAL ANESTHESIA; HUMAN; LETTER; MYASTHENIA; MYASTHENIA GRAVIS; NEUROMUSCULAR BLOCKING; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; THYMECTOMY; THYMOMA; TREATMENT OUTCOME;

EID: 1642499258     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200402000-00055     Document Type: Letter

References (8)

1. Dershwitz M, Rosow CE: Remifentanil: A truly short-acting opioid. Semin Anesth 1996; 15(1):88-96
2. Frank HJ, Shlugman D, Dershwitz M, Michalowski P, Malthouse-Dufore S, Connors PM, Martel D, Rosow CE, Muir KT, Rubin N, Glass P: Pharmacokinetics anesthesiologists, and phamacodynamics of remifentamil in persons with renal failure compared with healthy volunteers. Anesth Analg 1997; 87:533-41
3. Dershwitz M, Hoke JF, Rosow CE, Michalowski P, Connors PM, Muir KT, Dienstag JL: Pharmacokinetics and phamacodynamics of remifentanil in volunteer subjects with severe liver disease. Anesth Analg 1999; 84:812-20
4. Burkle H, Dunbar S, Van Aken H: Remifentanil: A novel, short-acting, mu-opioid. Anesth Analg. 1996; 83:646-51
5. Baraka A, Wakid N, Mansour R, Haddad W: Effect of neostigmine and pyridostigmine on the plasma cholinesterase activity. Br J Anaesth 1981; 53:849-51
6. Baraka A: Suxamethonium block in the myasthenic patient: Correlation with plasma cholinesterase. Anaesthesia 1992; 47:217-9
7. Davis PJ, Stiller RL, Wilson AS, McGowan FX, Egan T, Muir KT: In vitro remifentanil metabolism: The effects of whole blood constituents and plasma butyrylcholinesterase. Anesth Analg 2002; 95:1305-7
8. Manullang J, Egan T: Remifentanil's effect is not prolonged in a patient with pseudocholinesterase deficiency. Anesth Analg. 1999; 89:529-30